Intracoronary Eptifibatide During Primary Percutaneous Coronary Intervention in Early Versus Late Presenters with ST Segment Elevation Myocardial Infarction: A Randomized Trial.
Ayman ElbadawiGerald GasiochAkram Y ElgendyAhmed N MahmoudLe Dung HaHaitham Al AshryHend ShahinMohamed A HamzaAhmed S AbuzaidMarwan SaadPublished in: Cardiology and therapy (2016)
IC eptifibatide might improve the reperfusion markers during PPCI for STEMI patients presenting after 3 h from onset of symptoms. A large randomized study is recommended to ascertain the benefits of IC eptifibatide in late presenters on clinical outcomes.
Keyphrases
- st segment elevation myocardial infarction
- percutaneous coronary intervention
- st elevation myocardial infarction
- acute myocardial infarction
- acute coronary syndrome
- coronary artery disease
- end stage renal disease
- antiplatelet therapy
- coronary artery bypass grafting
- chronic kidney disease
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- atrial fibrillation
- coronary artery bypass
- case report
- heart failure
- cerebral ischemia
- blood brain barrier
- left ventricular
- patient reported outcomes
- subarachnoid hemorrhage